[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370238-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370238-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","golgi-scaffold-protein-paqr11-in-pan-cancer-landscape-a-comprehensive-bioinformatics-exploration","Golgi scaffold protein PAQR11 in pan-cancer landscape - A comprehensive bioinformatics exploration","","PAQR11 (progestin and adipoQ receptor family member 11) is evaluated as a regulator in cancer biology, linked to vesicle trafficking, mitogenic signaling, metastatic spread, lipid metabolism, and ferroptosis susceptibility. The study investigates whether PAQR11 expression relates to prognosis, immune responses, and drug sensitivity across diverse tumor types. Comprehensive pan-cancer bioinformatics analyses integrate public TCGA and multiple expression and immune datasets, aiming to clarify PAQR11’s biomarker and potential therapeutic target value in oncology.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/golgi-scaffold-protein-paqr11-in-pan-cancer-landscape-a-comprehensive-bioinformatics-exploration/370238/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/golgi-scaffold-protein-paqr11-in-pan-cancer-landscape-a-comprehensive-bioinformatics-exploration/370238.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is PAQR11 and why is it important in cancer?","Question",{"text":63,"@type":64},"PAQR11 (also known as MMD) functions as a Golgi/endomembrane scaffold protein involved in vesicle trafficking, mitogenic signaling, and metastatic promotion. It is also connected to lipid metabolism and ferroptosis susceptibility in cancer cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was PAQR11 analyzed across cancers in this study?",{"text":68,"@type":64},"The study performed comprehensive bioinformatics using publicly available pan-cancer datasets from TCGA and resources including GEO, UALCAN, TIMER, GEPIA2, KM plotter, and TISIDB, covering 33 cancer types and focusing on expression, prognosis, and immunological relevance.",{"name":70,"@type":61,"acceptedAnswer":71},"What relationships did the results show for PAQR11?",{"text":72,"@type":64},"PAQR11 expression was elevated in multiple cancer types and correlated with patient prognosis. The analysis also linked PAQR11 to immunological and epigenetic processes and identified a strong association between PAQR11 expression and drug sensitivity.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370238,1790245062,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","Heliyon 11 (2025) e41724  \nContents lists available at ScienceDirect  \nHeliyon  \njournal [homepage:](homepage: www.cell.com/heliyon)[ www.cell.com/heliyon](homepage: www.cell.com/heliyon)  \nReview article  \nGolgi scaffold protein PAQR11 in pan-cancer landscape: A comprehensive bioinformatics exploration of expression patterns, prognostic significance, and potential immunological function  \nZhu Liu a,b, Zhi-Qiang Ling a,b,*  \na Zhejiang Cancer Institute, Zhejiang Cancer Hospital, No.1 Banshan East Rd., Gongshu District, Hangzhou, 310022, Zhejiang, China b Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310018, China  \nA R T I C L E I N F O  \nKeywords:  \nProgestin and adipoQ receptor family member 11 (PAQR11)  \nMonocyte to macrophage differentiationassociated (MMD)  \nTCGA  \nPan-cancer analysis  \nPotential immunological function  \nA B S T R A C T  \nBackground: The progestin and adipoQ receptor family member, PAQR11, is recognized for its roles in vesicle trafficking, mitogenic signaling, and metastatic spread, positioning it as a crucial regulator in cancer biology. PAQR11 influences lipid metabolism and susceptibility to ferroptosisin cancer cells. This study aims to investigate the prognostic significance of PAQR11, its relevance to immune responses, and its association with drug sensitivity across various cancer types. By elucidating these aspects, the research seeks to assess PAQR11’s potential as a biomarker and therapeutic target in oncology.  \nMethods: We conducted a comprehensive bioinformatics analysis using publicly available pancancer datasets from TCGA, GEO, UALCAN, TIMER, GEPIA2, KM plotter, and TISIDB. This analysis encompassed gene expression profiles across 33 cancer types, with a focus on PAQR11’s expression patterns, prognostic significance, and immunological relevance. In addition, the study explored the correlation between PAQR11 expression and drug sensitivity, alongside its molecular and pathological characteristics in various tumors.  \nResults: Our findings demonstrate elevated PAQR11 expression levels across multiple cancer types, which significantly correlate with patient prognostic outcomes. The analysis further revealed PAQR11’s involvement in immunological and epigenetic processes, underscoring its critical role in cancer progression and treatment response. Notably, a strong correlation between PAQR11 expression and drug sensitivity was identified, suggesting its potential influence on the initiation and progression of various cancers and highlighting its promise as a therapeutic target. Conclusions: The comprehensive analysis of PAQR11 underscores its significance as a biomarker for cancer prognosis and its role in regulating immunological and epigenetic processes. These findings offer valuable insights that could inform early detection strategies and the development of novel therapeutic approaches. Further exploration and validation of PAQR11 are essential, highlighting the need for its integration into future oncological research and treatment strategy development.  \nTrial registration: Not applicable.  \n* Corresponding author. Cancer Institute, Zhejiang Cancer Hospital, No.1 Banshan East Rd., Gongshu District, Hangzhou, 310022, Zhejiang, China.  \nE-mail address: [lingzq@zjcc.org.cn](lingzq@zjcc.org.cn) (Z.-Q. Ling).  \n[https://doi.org/10.1016/j.heliyon.2025.e41724](https://doi.org/10.1016/j.heliyon.2025.e41724)  \nReceived 1 August 2024; Received in revised form 28 September 2024; Accepted 3 January 2025 Available online 4 January 2025  \n2405-8440/© 2025 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)).  \n1. Background  \nThe rising incidence of malignant tumors has increasingly become a critical factor affecting human life expectancy and quality of life [1,2]. Cancer imposes a substantial societal and econo","cbCaijBfqGreAi4k","https://ap.wps.com/l/cbCaijBfqGreAi4k","pdf",15171197,17,"English","# Background\n## PAQR11 in cancer biology\n# Methods\n## Pan-cancer bioinformatics datasets\n# Results\n## Expression, prognosis, and immune relevance\n# Conclusions\n## Biomarker potential and future validation","[{\"question\":\"What is PAQR11 and why is it important in cancer?\",\"answer\":\"PAQR11 (also known as MMD) functions as a Golgi/endomembrane scaffold protein involved in vesicle trafficking, mitogenic signaling, and metastatic promotion. It is also connected to lipid metabolism and ferroptosis susceptibility in cancer cells.\"},{\"question\":\"How was PAQR11 analyzed across cancers in this study?\",\"answer\":\"The study performed comprehensive bioinformatics using publicly available pan-cancer datasets from TCGA and resources including GEO, UALCAN, TIMER, GEPIA2, KM plotter, and TISIDB, covering 33 cancer types and focusing on expression, prognosis, and immunological relevance.\"},{\"question\":\"What relationships did the results show for PAQR11?\",\"answer\":\"PAQR11 expression was elevated in multiple cancer types and correlated with patient prognosis. The analysis also linked PAQR11 to immunological and epigenetic processes and identified a strong association between PAQR11 expression and drug sensitivity.\"}]","Golgi scaffold protein PAQR11 in pan-cancer landscape - A comprehensive bioinformatics exploration | PDF",1790187580,43,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc49e93054660e765107a15f9a312d84.webp",983,1341,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e197f4c74348ddb7be8c5954e9729bab.webp",982,1340,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97c081f0588168fc91032edf670e8c7f.webp",981,1338,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/530bfc300745516b02d60e20712d758f.webp",980,1337]